Show items per page
Elements: 378
Page 4 on 8
 TitleAuthors / EditorsDate
add to browser selection
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection Yerly Ferrillo, Sabine; Perneger, T. V.; Vora, S.; Hirschel, Bernard; Perrin, Luc 2000
add to browser selection
Investigations of axillary and inguinal adenopathies during primary human immunodeficiency virus infection: other lymphadenopathies could bring additional information Vanhems, P.; Hirschel, Bernard 2001
add to browser selection
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load Oxenius, A.; Gunthard, Huldrych; Hirschel, Bernard; Fidler, S.; ... Price, D. A. 2001
add to browser selection
Planned interruptions of anti-HIV treatment Hirschel, Bernard 2001
add to browser selection
Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis Kaiser, Laurent; Morabia, Alfredo; Stalder, Hans; Ricchetti, A.; ... Lew, Daniel Pablo 2001
add to browser selection
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study Fellay, Jacques; Boubaker, K.; Ledergerber, Bruno; Bernasconi, Enos; ... Telenti, A. 2001
add to browser selection
Modern anti-HIV therapy Flepp, Markus; Schiffer, V.; Weber, R.; Hirschel, Bernard 2001
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Fungemia in HIV-infected patients: a 12-year study in a tertiary care hospital Garbino, Jorge; Kolarova, L.; Lew, Daniel Pablo; Hirschel, Bernard; Rohner, Peter 2001
add to browser selection
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients Battegay, M.; Vernazza, P. L.; Bernasconi, Enos; Flepp, Markus; ... Hirschel, Bernard 2001
add to browser selection
Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000 Bernasconi, Enos; Jost, J.; Ledergerber, Bruno; Hirschel, Bernard; ... Sudre, Philippe 2001
add to browser selection
HIV transmission after suspension of highly active antiretroviral therapy Bernasconi, Enos; Vernazza, P. L.; Bernasconi, Alessandra; Hirschel, Bernard 2001
add to browser selection
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study Boubaker, K.; Flepp, Markus; Sudre, Philippe; Furrer, Hansjakob; ... Telenti, A. 2001
add to browser selection
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance Yerly Ferrillo, Sabine; Vora, S.; Rizzardi, P.; Chave, J. P.; ... Perrin, Luc 2001
add to browser selection
Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts Fischer, Marek; Wong, J. K.; Russenberger, Doris; Joos, Beda; ... Gunthard, Huldrych 2002
add to browser selection
Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study Taffe, Patrick; Rickenbach, Martin; Hirschel, Bernard; Opravil, Milos; ... Sudre, Philippe 2002
add to browser selection
The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individual Vanhems, Philippe; Caillat-Vallet, Emmanuelle; Hirschel, Bernard; Routy, J. P.; ... Perrin, Luc 2002
add to browser selection
Clinical features of acute retroviral syndrome differ by route of infection but not by gender and age Vanhems, Philippe; Routy, J. P.; Hirschel, Bernard; Baratin, Dominique; ... Perrin, Luc 2002
add to browser selection
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection Opravil, Milos; Hirschel, Bernard; Lazzarin, Adriano; Furrer, Hansjakob; ... Perrin, Luc 2002
add to browser selection
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) Opravil, Milos; Ledergerber, Bruno; Furrer, Hansjakob; Hirschel, Bernard; ... Weber, Rainer 2002
add to browser selection
Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy Oxenius, Annette; McLean, A. R.; Fischer, Marek; Price, D. A.; ... Gunthard, Huldrych 2002
add to browser selection
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load Oxenius, Annette; Price, D. A.; Dawson, S. J.; Gunthard, Huldrych; ... Phillips, R. E. 2002
add to browser selection
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection Oxenius, Annette; Price, D. A.; Gunthard, Huldrych; Dawson, S. J.; ... Phillips, R. E. 2002
add to browser selection
Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load Oxenius, Annetie; Sewell, A. K.; Dawson, S. J.; Gunthard, Huldrych; ... Price, D. A. 2002
add to browser selection
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort Hirschel, Bernard; Flepp, Markus; Bucher, H. C.; Zellweger, Claudine; ... Ledergerber, Bruno 2002
add to browser selection
New drugs, old drugs - dear drugs, cheap drugs Hirschel, Bernard; Garbino, Jorge 2002
add to browser selection
A patient with HIV-1 superinfection Jost, Stéphanie; Bernard, Marie-Charlotte; Kaiser, Laurent; Yerly Ferrillo, Sabine; ... Perrin, Luc 2002
add to browser selection
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study Mocroft, A.; Phillips, A. N.; Friis-Moller, N.; Colebunders, R.; ... Lundgren, J. D. 2002
add to browser selection
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy Greub, Gilbert; Cozzi-Lepri, Alessandro; Ledergerber, Bruno; Staszewski, Schlomo; ... Telenti, Amalio 2002
add to browser selection
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study Bernasconi, Enos; Boubaker, Karim; Junghans, Cornelia; Flepp, Markus; ... Telenti, Amalio 2002
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Weight-losing HIV-infected patients on recombinant human growth hormone for 12 wk: a national study Cominelli, Silvano; Raguso, C. A.; Karsegard, Laurie; Hirschel, Bernard; ... Pichard, Claude 2002
add to browser selection
Supervised interruptions of antiretroviral therapy Deeks, S. G.; Hirschel, Bernard 2002
add to browser selection
Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection Trkola, Alexandra; Kuster, Herbert; Leemann, Christine; Ruprecht, Claudia; ... Gunthard, Huldrych 2003
add to browser selection
Prophylaxie post-exposition au VIH de Lucia, Sylvain; Hirschel, Bernard 2003
add to browser selection
Caspofungin in the treatment of oropharyngeal candidiasis Garbino, Jorge; Lew, Daniel Pablo; Hirschel, Bernard; Rohner, Peter 2003
add to browser selection
Is autovaccination dead? Hirschel, Bernard 2003
add to browser selection
Structured treatment interruptions in HIV infection: benefit or disappointment? Oxenius, Annette; Hirschel, Bernard 2003
add to browser selection
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival Staehelin, Cornelia; Rickenbach, Martin; Low, Nicola; Egger, Martin; ... Furrer, Hansjakob 2003
add to browser selection
Brief report: incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS Vanhems, Philippe; Voirin, Nicolas; Hirschel, Bernard; Cooper, David; ... Perrin, Luc 2003
add to browser selection
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study Wolf, Katja; Young, James; Rickenbach, Martin; Vernazza, Pietro; ... Bucher, H. C. 2003
add to browser selection
Drug resistance mutations during structured treatment interruptions Yerly Ferrillo, Sabine; Fagard, Catherine; Gunthard, Huldrych; Hirschel, Bernard; Perrin, Luc 2003
add to browser selection
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection Hirsch, M. S.; Steigbigel, R. T.; Staszewski, Scholomo; McMahon, Deborah; ... Leavitt, R. Y. 2003
add to browser selection
Antiretroviral treatment and research in resource-poor countries Hirschel, Bernard 2003
add to browser selection
Questions about the antimalarial amodiaquine Hirschel, Bernard 2003
add to browser selection
Beware of drug holidays before HIV salvage therapy Hirschel, Bernard 2003
add to browser selection
Substitution for protease inhibitors in HIV therapy Hirschel, Bernard 2003
add to browser selection
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy, by Cohen et al Hirschel, Bernard 2003
add to browser selection
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, by Matthews et al Hirschel, Bernard 2003
add to browser selection
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients, by Ghosn et al Hirschel, Bernard 2003
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |